-
1
-
-
0025265635
-
Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis
-
TUGWELL P, BOMBARDIER C, GENT M et al.: Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet 1990; 335: 1051-5.
-
(1990)
Lancet
, vol.335
, pp. 1051-1055
-
-
TUGWELL, P.1
BOMBARDIER, C.2
GENT, M.3
-
2
-
-
23444449002
-
A randomized, double-blind, 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritis
-
LANDEWE RB, GOEI THE HS, VAN RIJTHOVEN AW, BREEDVELD FC, DIJKMANS BA: A randomized, double-blind, 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritis. Arthritis Rheum 1994; 37: 637-43.
-
(1994)
Arthritis Rheum
, vol.37
, pp. 637-643
-
-
LANDEWE, R.B.1
GOEI, T.H.2
-
3
-
-
0027987025
-
Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine. Results of a 48-week multicenter study comparing low-dose cyclosporine with placebo. Norwegian Arthritis Study Group
-
FØRRE O: Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine. Results of a 48-week multicenter study comparing low-dose cyclosporine with placebo. Norwegian Arthritis Study Group. Arthritis Rheum 1994; 37: 1506-12.
-
(1994)
Arthritis Rheum
, vol.37
, pp. 1506-1512
-
-
FØRRE, O.1
-
4
-
-
8944256867
-
Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A
-
PASERO G, PRIOLO F, MARUBINI E et al.: Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A. Arthritis Rheum 1996; 39: 1006-15.
-
(1996)
Arthritis Rheum
, vol.39
, pp. 1006-1015
-
-
PASERO, G.1
PRIOLO, F.2
MARUBINI, E.3
-
5
-
-
0030067972
-
Post-transplantatiTn bone disease: The role of immunosuppressive agents and the skeleton
-
EPSTEIN S: Post-transplantatiTn bone disease: the role of immunosuppressive agents and the skeleton. J Bone Miner Res 1996; 11: 1-7.
-
(1996)
J Bone Miner Res
, vol.11
, pp. 1-7
-
-
EPSTEIN, S.1
-
6
-
-
0028348583
-
The deleterious effects of long-term cyclosporine A, cyclosporine G and FK506 on bone mineral metabolism in vivo
-
CVETKOVIC M, MANN GN, ROMERO DF et al.: The deleterious effects of long-term cyclosporine A, cyclosporine G and FK506 on bone mineral metabolism in vivo. Transplantation 1994; 57: 1231-7.
-
(1994)
Transplantation
, vol.57
, pp. 1231-1237
-
-
CVETKOVIC, M.1
MANN, G.N.2
ROMERO, D.F.3
-
7
-
-
0023708625
-
Cyclosporine A in vivo produces severe osteopenia in the rat: Effect of dose and duration of administration
-
MVSOWITZ C, EPSTEIN S, FALLON M et al.: Cyclosporine A in vivo produces severe osteopenia in the rat: Effect of dose and duration of administration. Endocrinology 1988; 123: 2571-7.
-
(1988)
Endocrinology
, vol.123
, pp. 2571-2577
-
-
MVSOWITZ, C.1
EPSTEIN, S.2
FALLON, M.3
-
8
-
-
0027954919
-
Influence of age on cyclosporine A-induced alterations in bone mineral metabolism in the rat in vivo
-
KATZ I, LI MEI, JOFFE I et al.: Influence of age on cyclosporine A-induced alterations in bone mineral metabolism in the rat in vivo. J Bone Miner Res 1994; 9: 59-67.
-
(1994)
J Bone Miner Res
, vol.9
, pp. 59-67
-
-
KATZ, I.1
LI, M.E.I.2
JOFFE, I.3
-
9
-
-
0032971518
-
Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation
-
EBELING PR, THOMAS DM, ERBAS B, HOPPER JL, SZER J, GRIGG AP: Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation. J Bone Miner Res 1999; 14: 342-50.
-
(1999)
J Bone Miner Res
, vol.14
, pp. 342-350
-
-
EBELING, P.R.1
THOMAS, D.M.2
ERBAS, B.3
HOPPER, J.L.4
SZER, J.5
GRIGG, A.P.6
-
10
-
-
0027402804
-
Osteoporosis after cardiac transplantation
-
SHANE E, RIVAS MC, SILVERBERG SJ, KIM TS, STARON RB, BILEZIKIAN JP: Osteoporosis after cardiac transplantation. Am J Med 1993; 94: 257-64.
-
(1993)
Am J Med
, vol.94
, pp. 257-264
-
-
SHANE, E.1
RIVAS, M.C.2
SILVERBERG, S.J.3
KIM, T.S.4
STARON, R.B.5
BILEZIKIAN, J.P.6
-
11
-
-
0029763501
-
Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation
-
THIEBAUD D, KRIEG MA, GILLARD-BERGUER D, JACQUET AF, GOY JJ, BURCKHARDT P: Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation. Eur J Clin Invest 1996; 26 549-55.
-
(1996)
Eur J Clin Invest
, vol.26
, pp. 549-555
-
-
THIEBAUD, D.1
KRIEG, M.A.2
GILLARD-BERGUER, D.3
JACQUET, A.F.4
GOY, J.J.5
BURCKHARDT, P.6
-
12
-
-
0029046374
-
Prevention of cancellous bone loss but persistence of renal bone disease despite normal 1, 25 vitamin D levels two years after kidney transplantation
-
BRINER VA, THIEL G, MONIER-FAUGERE MC et al.: Prevention of cancellous bone loss but persistence of renal bone disease despite normal 1, 25 vitamin D levels two years after kidney transplantation. Transplantation 1995; 59: 1393-400.
-
(1995)
Transplantation
, vol.59
, pp. 1393-1400
-
-
BRINER, V.A.1
THIEL, G.2
MONIER-FAUGERE, M.C.3
-
13
-
-
0028923370
-
Long-term bone loss after renal transplCntation: Comparison of immunosuppressive regimens
-
MCINTYRE HD, MENZIES B, RIGBY R, PERRY KEENE DA, HAWLEY CM, HARDIE IR: Long-term bone loss after renal transplCntation: comparison of immunosuppressive regimens. Clin Transpl 1995; 9: 20-4.
-
(1995)
Clin Transpl
, vol.9
, pp. 20-24
-
-
MCINTYRE, H.D.1
MENZIES, B.2
RIGBY, R.3
-
14
-
-
0031016377
-
Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients - a prospective study
-
AROLDI A, TARANTINO A, MONTAGNINO G, CESANA B, COCUCCI C, PONTICELLI C: Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients - a prospective study. Transplantation 1997; 63: 380-6.
-
(1997)
Transplantation
, vol.63
, pp. 380-386
-
-
AROLDI, A.1
TARANTINO, A.2
MONTAGNINO, G.3
CESANA, B.4
COCUCCI, C.5
PONTICELLI, C.6
-
15
-
-
0031965305
-
Long-term bone densitometry post-renal transplantation in patients treated with either cyclosporine or prednisolone
-
PARRY RG, JACKSON J, STEVENS JM, HIGGINS B, ALTMANN P: Long-term bone densitometry post-renal transplantation in patients treated with either cyclosporine or prednisolone. Nephrol Dial Transplant 1998; 13: 531-2.
-
(1998)
Nephrol Dial Transplant
, vol.13
, pp. 531-532
-
-
PARRY, R.G.1
JACKSON, J.2
STEVENS, J.M.3
HIGGINS, B.4
ALTMANN, P.5
-
16
-
-
0032917787
-
Bone loss in long-term renal transplantation: Histopathology and densitometry analysis
-
CUETO-MANZANO AM, KONEL S, HUTCHISON AJ et al.: Bone loss in long-term renal transplantation: Histopathology and densitometry analysis. Kidney Int 1999; 55: 2021-9.
-
(1999)
Kidney Int
, vol.55
, pp. 2021-2029
-
-
CUETO-MANZANO, A.M.1
KONEL, S.2
HUTCHISON, A.J.3
-
17
-
-
0033797498
-
Cyclosporine bone remodelling effect prevents steroid osteopenia after kidney transplantation
-
WESTEEL FP, MAZOUZ H, EZAITOUNI F et al.: Cyclosporine bone remodelling effect prevents steroid osteopenia after kidney transplantation. Kidney Int 2000; 58: 1788-96.
-
(2000)
Kidney Int
, vol.58
, pp. 1788-1796
-
-
WESTEEL, F.P.1
MAZOUZ, H.2
EZAITOUNI, F.3
-
18
-
-
0029742877
-
Increase of bone mineral density and anabolic variables in patients with rheumatoid arthritis resistant to methotrexate after cyclosporin A therapy
-
FERRACCIOLI G, CASATTA L, BARTOLI E: Increase of bone mineral density and anabolic variables in patients with rheumatoid arthritis resistant to methotrexate after cyclosporin A therapy. J Rheumatol 1996; 23: 1539-42.
-
(1996)
J Rheumatol
, vol.23
, pp. 1539-1542
-
-
FERRACCIOLI, G.1
CASATTA, L.2
BARTOLI, E.3
-
19
-
-
0033748422
-
A multicenter cross sectional study on bone mineral density in rheumatoid arthritis
-
SINIGAGLIA L, NERVEITI A, MELA Q et al.: A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. J Rheumatol 2000; 27: 2582-9.
-
(2000)
J Rheumatol
, vol.27
, pp. 2582-2589
-
-
SINIGAGLIA, L.1
NERVEITI, A.2
MELA, Q.3
-
20
-
-
3042770431
-
Effect of low dose methotrexate on bone density in women with rheumatoid arthritis: Results from a multicenter cross-sectional study
-
DI MUNNO O, MAZZANTINI M, SINIGAGLIA L et al.: Effect of low dose methotrexate on bone density in women with rheumatoid arthritis: Results from a multicenter cross-sectional study. J Rheumatol 2004; 31: 1305-9.
-
(2004)
J Rheumatol
, vol.31
, pp. 1305-1309
-
-
DI MUNNO, O.1
MAZZANTINI, M.2
SINIGAGLIA, L.3
-
21
-
-
0034047128
-
Vertebral bone mineral density changes in female rheumatoid arthritis patients treated with low-dose methotrexate
-
MAZZANTINI M, INCERTI-VECCHI L, DI MUNNO O, PASERO O: Vertebral bone mineral density changes in female rheumatoid arthritis patients treated with low-dose methotrexate. Clin Exp Rheumatol 2000; 18: 327-31.
-
(2000)
Clin Exp Rheumatol
, vol.18
, pp. 327-331
-
-
MAZZANTINI, M.1
INCERTI-VECCHI, L.2
DI MUNNO, O.3
PASERO, O.4
-
23
-
-
37349074562
-
-
WHO STUDY GROUP: Osteoporosis. In: Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis. Technical Report Series 843. Geneva, WHO, 1994: 2-25.
-
WHO STUDY GROUP: Osteoporosis. In: Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis. Technical Report Series 843. Geneva, WHO, 1994: 2-25.
-
-
-
-
24
-
-
0019407824
-
Preliminary criteria for clinical remission in rheumatoid arthritis
-
PINALS RS, MASI AT, LARSEN RA: Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981; 24: 1308-15.
-
(1981)
Arthritis Rheum
, vol.24
, pp. 1308-1315
-
-
PINALS, R.S.1
MASI, A.T.2
LARSEN, R.A.3
-
26
-
-
17844410337
-
Clinical review: Osteoporosis after solid organ transplantation
-
MAALOUF NM,OSHANE E: Clinical review: osteoporosis after solid organ transplantation. J Clin Endrocrinol Metab 2005; 90: 2456-65.
-
(2005)
J Clin Endrocrinol Metab
, vol.90
, pp. 2456-2465
-
-
MAALOUF, N.M.1
OSHANE, E.2
-
27
-
-
16244372694
-
Post-transplantation bone disease
-
CUNNINGHAM J: Post-transplantation bone disease. Transplantation 2005: 79: 629-34.
-
(2005)
Transplantation
, vol.79
, pp. 629-634
-
-
CUNNINGHAM, J.1
-
28
-
-
0034817070
-
Effects of immunosuppressants on the receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth cells
-
HOFBAUER LC, SHUI C, RIGGS BL et al.: Effects of immunosuppressants on the receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth cells. Biochem Biophys Res Commun 2001: 280: 334-9.
-
(2001)
Biochem Biophys Res Commun
, vol.280
, pp. 334-339
-
-
HOFBAUER, L.C.1
SHUI, C.2
RIGGS, B.L.3
-
29
-
-
26944454882
-
Bone metabolism in renal transplant patients treated with cyclosporine or sirolimus
-
and the SIROLIMUS EUROPEAN RENAL TRANSPLANT STUDY GROUP
-
CAMPISTOL JM, HOLT DW, EPSTEIN S, GIOUD-PAQUET M, RUTAULT K, BURKE JT and the SIROLIMUS EUROPEAN RENAL TRANSPLANT STUDY GROUP: Bone metabolism in renal transplant patients treated with cyclosporine or sirolimus. Transpl Int 2005; 18: 1028-35.
-
(2005)
Transpl Int
, vol.18
, pp. 1028-1035
-
-
CAMPISTOL, J.M.1
HOLT, D.W.2
EPSTEIN, S.3
GIOUD-PAQUET, M.4
RUTAULT, K.5
BURKE, J.T.6
|